Model Number 71992-01 |
Device Problem
Device Alarm System (1012)
|
Patient Problems
Hyperglycemia (1905); Diabetic Ketoacidosis (2364); Loss of consciousness (2418); Diaphoresis (2452)
|
Event Date 08/25/2023 |
Event Type
Injury
|
Event Description
|
An alarm issue was reported with the adc device.Customer experienced a signal loss and was unable to obtain readings and receive glucose alarms.As a result, customer was not alerted of changes in glucose level and experienced hyperglycemia with symptoms described as sweating, slow breathing, and a loss of consciousness and was unable to self-treat, requiring treatment of insulin and "solutions" by a hcp for a diabetic ketoacidosis diagnosis.No further treatment was indicated.There was no report of death or permanent impairment associated with this event.
|
|
Manufacturer Narrative
|
The product has been requested back for an investigation.A follow-up report will be submitted once additional information is obtained.The device manufacturing date is unknown.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
|
Manufacturer Narrative
|
Additional information: section d4 (udi) was updated.Additional investigation has been conducted for the reported complaint.The user reported signal loss and was unable to obtain readings and receive glucose alarms in freestyle librelink app.Attempts to replicate the users complaint using a similar configuration was performed.The reported issue was unable to be replicated and the system functioned as intended.There were no issues identified with the freestyle librelink app during replication that would have led to the reported issue.No malfunction or product deficiency was identified.If the product is returned, the case will be re-opened, and a physical investigation will be performed.All pertinent information available to abbott diabetes care has been submitted.
|
|
Event Description
|
An alarm issue was reported with the adc device.Customer experienced a signal loss and was unable to obtain readings and receive glucose alarms.As a result, customer was not alerted of changes in glucose level and experienced hyperglycemia with symptoms described as sweating, slow breathing, and a loss of consciousness and was unable to self-treat, requiring treatment of insulin and "solutions" by a hcp for a diabetic ketoacidosis diagnosis.No further treatment was indicated.There was no report of death or permanent impairment associated with this event.
|
|
Event Description
|
An alarm issue was reported with the adc device.Customer experienced a signal loss and was unable to obtain readings and receive glucose alarms.As a result, customer was not alerted of changes in glucose level and experienced hyperglycemia with symptoms described as sweating, slow breathing, and a loss of consciousness and was unable to self-treat, requiring treatment of insulin and "solutions" by a hcp for a diabetic ketoacidosis diagnosis.No further treatment was indicated.There was no report of death or permanent impairment associated with this event.
|
|
Manufacturer Narrative
|
Repeated attempts by adc to retrieve the product were unsuccessful and/or the customer discarded the product.No product has been returned the most probable root causes associated with this failure mode are software/data corruption, or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.At this time product has not yet been returned for this complaint.An extended investigation has been performed for the reported complaint.The dhr for the libre sensor and sensor kit indicated by the serial number provided by the customer was reviewed.The dhrs showed the libre sensor and sensor kits passed all tests prior to release and there was no indication that the product did not meet specifications.If the product is returned, the case will be re-opened, and a physical investigation will be performed.All pertinent information available to abbott diabetes care has been submitted.
|
|
Search Alerts/Recalls
|